...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis.
【24h】

Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis.

机译:不需要慢性透析的慢性肾脏疾病患者的甲状腺自身免疫和亚临床甲状腺功能减退症的患病率。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The prevalence of thyroid autoimmunity and subclinical primary hypothyroidism in persons with chronic kidney disease (CKD) not requiring chronic dialysis is not well defined. METHODS: We studied 1000 consecutive adult outpatients who were referred by their general practitioner for blood testing over the last 2 years. We excluded those with abnormal serum free thyroxine (FT4) levels (n=85). No participants required chronic renal replacement therapy. Thyroid autoimmunity was defined as increased concentrations of serum anti-thyroid antibodies. Subclinical primary hypothyroidism was defined as a serum thyrotropin (TSH) concentration >4 mIU/L. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2). RESULTS: Overall, 53 (5.8%) subjects had eGFR <60 mL/min/1.73 m(2). Of these, 98 (10.7%) had subclinical hypothyroidism, and 213 (23.3%) subjects had increased anti-thyroid antibodies. Approximately 26% and 34% of those with eGFR <60 mL/min/1.73 m(2) had laboratory evidence of subclinical hypothyroidism or thyroid autoimmunity, respectively. In subgroup analysis stratified by TSH and thyroid autoimmunity, decreasing eGFR values appeared to be more strongly related with the increase in TSH rather than antithyroid antibodies. CONCLUSIONS: Thyroid autoimmunity and subclinical primary hypothyroidism are highly prevalent in persons with CKD not requiring chronic dialysis.
机译:背景:对于不需要长期透析的慢性肾脏病(CKD)患者,甲状腺自身免疫和亚临床原发性甲状腺功能减退症的患病率尚不明确。方法:我们研究了近两年来由其全科医生转诊进行血液检测的连续1000名成人门诊患者。我们排除了血清游离甲状腺素(FT4)水平异常的患者(n = 85)。没有参与者需要慢性肾脏替代治疗。甲状腺自身免疫定义为血清抗甲状腺抗体浓度增加。亚临床原发性甲状腺功能减退症定义为血清促甲状腺激素(TSH)浓度> 4 mIU / L。 CKD定义为估计的肾小球滤过率(eGFR)<60 mL / min / 1.73 m(2)。结果:总体上,有53名(5.8%)受试者的eGFR <60 mL / min / 1.73 m(2)。在这些患者中,有98名(10.7%)患有亚临床甲状腺功能减退症,而213名(23.3%)的受试者具有增加的抗甲状腺抗体。 eGFR <60 mL / min / 1.73 m(2)的患者中,分别有约26%和34%的实验室证据显示亚临床甲状腺功能减退症或甲状腺自身免疫性。在以TSH和甲状腺自身免疫性分层的亚组分析中,eGFR值降低似乎与TSH升高而不是抗甲状腺抗体密切相关。结论:在不需要慢性透析的CKD患者中,甲状腺自身免疫和亚临床原发性甲状腺功能减退症非常普遍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号